We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
+13.09%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$323M
AUM Growth
+$14.5M
(+4.7%)
Cap. Flow
-$9.38M
Cap. Flow
% of AUM
-2.91%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
40
New
–
Increased
2
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$1.13M |
| 2 |
Fate Therapeutics
FATE
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$4.26M |
| 2 |
CMS Energy
CMS
|
+$2.87M |
| 3 |
Duke Energy
DUK
|
+$2.43M |
| 4 |
LVTX
LAVA Therapeutics
LVTX
|
+$689K |
| 5 |
Kodiak Sciences
KOD
|
+$377K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.27% |
| 2 | Utilities | 24.23% |
| 3 | Industrials | 19.38% |
| 4 | Financials | 9.17% |
| 5 | Consumer Staples | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$450B
| $29.5M | 9.14% |
127,500
| – | – |
|
2
Allstate
ALL
$64.3B
| $26.9M | 8.34% |
125,500
| – | – |
|
3
NextEra Energy
NEE
$185B
| $23.8M | 7.36% |
315,000
| – | – |
|
4
U-Haul Holding Co Series N
UHAL.B
$12.2B
| $23M | 7.12% |
452,000
| – | – |
|
5
AerCap
AER
$23.2B
| $22.2M | 6.88% |
183,500
| – | – |
|
|
6
Duke Energy
DUK
$97.5B
| $19.3M | 5.97% |
155,816
-20,000
| -11% | -$2.43M |
|
7
Abbott
ABT
$175B
| $17.9M | 5.55% |
133,800
| – | – |
|
8
Merck
MRK
$315B
| $16.2M | 5.01% |
192,800
| – | – |
|
9
Xcel Energy
XEL
$49.2B
| $15.7M | 4.86% |
194,500
| – | – |
|
|
10
AT&T
T
$152B
| $14.8M | 4.57% |
523,000
-150,000
| -22% | -$4.26M |
|
11
Insteel Industries
IIIN
$602M
| $13.2M | 4.08% |
343,423
| – | – |
|
|
12
CMS Energy
CMS
$22.8B
| $11.4M | 3.54% |
156,000
-40,000
| -20% | -$2.87M |
|
13
Apple
AAPL
$4.9T
| $9.91M | 3.07% |
38,900
| – | – |
|
14
Newmont
NEM
$95.8B
| $8.43M | 2.61% |
100,000
| – | – |
|
15
Avista
AVA
$3.45B
| $7.62M | 2.36% |
201,500
| – | – |
|
16
Pfizer
PFE
$143B
| $6.93M | 2.15% |
271,900
| – | – |
|
17
Bunge Global
BG
$23.1B
| $6.5M | 2.01% |
80,000
| – | – |
|
18
Archer Daniels Midland
ADM
$41.4B
| $5.97M | 1.85% |
100,000
| – | – |
|
|
19
Kodiak Sciences
KOD
$2.67B
| $4.57M | 1.42% |
279,308
-43,692
| -14% | -$377K |
|
20
Vicor
VICR
$10.8B
| $4.47M | 1.39% |
90,000
| – | – |
|
|
21
U-Haul Holding Co
UHAL
$13.9B
| $4.22M | 1.31% |
73,900
| – | – |
|
22
Darling Ingredients
DAR
$10B
| $4.04M | 1.25% |
131,000
| – | – |
|
23
Chemours
CC
$2.63B
| $3.96M | 1.23% |
250,000
| – | – |
|
24
Supernus Pharmaceuticals
SUPN
$2.79B
| $3.92M | 1.22% |
82,105
| – | – |
|
|
25
LyondellBasell Industries
LYB
$19.1B
| $2.94M | 0.91% |
60,000
+20,000
| +50% | +$1.13M |
|
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q3 2025 Portfolio in Review
As of Q3 2025, Bruce & Co held 40 positions worth $323M, up 4.7% from $308M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 2.5%. Bruce & Co opened no new positions and exited 1, leaving the 40-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Utilities and Industrials.
- Bruce & Co added most to LyondellBasell Industries in Q3 2025, an estimated $1.13M increase.
- Bruce & Co's biggest Q3 2025 reduction was AT&T, cutting an estimated $4.26M.
- Bruce & Co fully exited LAVA Therapeutics in Q3 2025, selling an estimated $689K.
- Bruce & Co's ten largest holdings make up 65% of its $323M portfolio in Q3 2025.
- Bruce & Co opened 0 new positions and closed 1 in Q3 2025.
- Bruce & Co's portfolio value rose 4.7% quarter-over-quarter to $323M.
Based on Bruce & Co's 13F filing for Q3 2025, filed 13 Nov 2025.